Costs for Emergency Allergy Injectors Still High for Some?

July 12, 2022

 • 

Read time:

<5 mins
Money 1200
Presented by Health Lab

A new study, led by Kao-Ping Chua, M.D., Ph.D., a U-M pediatrician, sheds light on the affordability of epinephrine auto-injectors, finding that children and adults with high deductible health plans are paying significantly more for the life-saving medication even as competitors to EpiPen became available. Chua, a member of the Susan B. Meister Child Health Evaluation and Research (CHEAR) Center and the U-M Institute for Healthcare Policy and Innovation, explores the findings and provides suggestions to help increase affordability for patients with severe allergies.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.